The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
State-dependent opioid control of pain
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The high concentration of opioid receptors expressed in rACC (Vogt et al., 1993; Fields, 2004) has been hypothesized to relate to attentional mechanisms that can suppress pain processing (Petrovic et al., 2002), a suggestion that has received experimental support (Zubieta et al., 2005; Wager et al., 2007; Eippert et al., 2009).”
From Top-Down Dysregulation—From ADHD to Emotional Instability (2016) · cites this paper as Fields, 2004
Citations
Cites
Molecular mechanisms of nociception
Julius, D., & Basbaum, A. I. (2001) · Nature · doi:10.1038/35093019 · Cited by 2,685 · cited 1×
“We now know a great deal about the molecular mechanisms of transduction and the relationship of the firing of these neurons to stimulus intensity and to the psychophysics of perceived pain intensit”
BackgroundTHE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Self-citationOrganization of endogenous opiate and nonopiate pain control systems
Watkins, L. R., & Mayer, D. J. (1982) · Science · doi:10.1126/science.6281891 · Cited by 791
Response expectancies in placebo analgesia and their clinical relevance
Pollo, A., Amanzio, M., Arslanian, A., Casadio, C., Maggi, G., & Benedetti, F. (2001) · Pain · doi:10.1016/s0304-3959(01)00296-2 · Cited by 442
Liebeskind, J. C., Guilbaud, G., Besson, J.-M., & Oliveras, J.-L. (1973) · Brain Research · doi:10.1016/0006-8993(73)90748-8 · Cited by 439
The role of conditioning and verbal expectancy in the placebo response
Voudouris, N. J., Peck, C. L., & Coleman, G. (1990) · Pain · doi:10.1016/0304-3959(90)90057-k · Cited by 369
Sucrose ingestion causes opioid analgesia.
Segato, F. N., Castro-Souza, C., Segato, E. N., Morato, S., & Coimbra, N. C. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000800011 · Cited by 72
Flagged first, then by citations
Research works printed but not linked: 128
- Melzack, R. & Wall, P. D. Acute pain in an emergency clinic: latency of onset and descriptor patterns related to different injuries. Pain 14, 33–43 (1982). · DOI
- Akil, H. et al. Endogenous opioids: overview and current issues. Drug Alcohol Depend. 51, 127–140 (1998). · DOI
- Kieffer, B. L. & Gaveriaux-Ruff, C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285–306 (2002). · DOI · Paper page
- Fields, H. L., Heinricher, M. M. & Mason, P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14, 219–245 (1991). · DOI
- Yaksh, T. L. & Rudy, T. A. Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 4, 299–359 (1978). This is a thorough review of the initial mapping studies of CNS sites that are sensitive to the analgesic effect of opioids. · DOI
- Heinricher, M. M. & McGaraughty, S. in State-Dependent Processing in Somatosensory Pathways (ed. Soja, P. J.) 487–503 (CRC Press, San Diego, 1998).
- Fields, H. L. & Basbaum, A. I. in Textbook of Pain (eds Wall, P. D. & Melzack, R.) 309–329 (Churchill Livingstone, Edinburgh, 1999).
- Neubert, M. J., Kincaid, W. & Heinricher, M. M. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain (in the press). By selectively activating on cells, the authors provide definitive evidence that these cells facilitate nociceptive transmission. · DOI
- Ackley, M. A., Hurley, R. W., Virnich, D. E. & Hammond, D. L. A cellular mechanism for the antinociceptive effect of a κ-opioid receptor agonist. Pain 91, 377–388 (2001). The authors demonstrate presynaptic control of glutamatergic inputs by KOR agonists in vitro. · DOI
- Chieng, B. & Christie, M. J. Hyperpolarization by opioids acting on μ-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br. J. Pharmacol. 113, 121–128 (1994). · DOI
- Pan, Z. Z., Tershner, S. A. & Fields, H. L. Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor. Nature 389, 382–385 (1997). · DOI
- Price, D. D. Psychological Mechanisms of Pain and Analgesia (IASP Press, Seattle, 1999). A classic book in which the author presents a thorough review of the psychophysics of pain, and of the cognitive and experiential modifiers of pain. He puts this perceptual evidence into a neurobiological and clinical perspective.
- Willis, W. D. & Coggeshall, R. E. Sensory Mechanisms of the Spinal Cord (Plenum, New York, 1991). · DOI
- Wall, P. D. & Melzack, R. (eds) Textbook of Pain (Churchill Livingstone, Edinburgh, 1999).
- Casey, K. L. & Bushnell, M. C. (eds) Pain Imaging (IASP Press, Seattle, 2000).
- Wall, P. D. The laminar organisation of dorsal horn and effects of descending impulses. J. Physiol. (Lond.) 188, 403–423 (1967). This is a seminal description of dorsal horn neurons as feature detectors with response properties that are subject to top–down modulation. Wall demonstrated that each dorsal horn lamina contained neurons with distinct physiological properties, and he placed the main focus of pain research on the spinal cord. · DOI
- Reynolds, D. V. Surgery in the rat during electrical analgesia by focal brain stimulation. Science 164, 444–445 (1969). The original description of stimulation-produced analgesia in rodents. · DOI
- Mayer, D. J., Wolfe, T. L., Akil, H., Carder, B. & Liebeskind, J. C. Analgesia from electrical stimulation in the brain stem of the rat. Science 174, 1351–1354 (1971). · DOI
- Mayer, D. J. & Liebeskind, J. C. Pain reduction by focal stimulation of the brain: an anatomical and behavioural analysis. Brain Res. 68, 73–93 (1974). · DOI
- Hosobuchi, Y., Adams, J. E. & Linchitz, R. Pain relief by electrical stimulation of the central gray matter in humans in its reversal by naloxone. Science 197, 183–186 (1977). · DOI
- Baskin, D. S. et al. Autopsy analysis of the safety, efficacy and cartography of electrical stimulation of the central gray in humans. Brain Res. 371, 231–236 (1986). · DOI
- Holden, J. E., van Poppel, A. Y. & Thomas, S. Antinociception from lateral hypothalamic stimulation may be mediated by NK1 receptors in the A7 catecholamine cell group in rat. Brain Res. 953, 195–204 (2002). · DOI
- Stein, C., Schafer, M. & Machelska, H. Attacking pain at its source: new perspectives on opioids. Nature Med. 9, 1003–1008 (2003). · DOI
- Grudt, T. J. & Williams, J. T. μ-opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat. J. Neurosci. 14, 1646–1654 (1994). · DOI
- Glaum, S. R., Miller, R. J. & Hammond, D. L. Inhibitory actions of δ1, δ2, and μ-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J. Neurosci. 14, 4965–4971 (1994). This study demonstrates both pre- and postsynaptic actions of opioids at the first relay from primary afferent nociceptors to second-order dorsal horn neurons. · DOI
- Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H. & Watson, S. J. Anatomy of CNS opioid receptors. Trends Neurosci. 11, 308–314 (1988). · DOI
- Mansour, A., Fox, C. A. & Watson, S. J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22–29 (1995). A concise survey of MOR, KOR and DOR distribution in the CNS. · DOI
- Arvidsson, U. et al. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15, 3328–3341 (1995). · DOI
- Manning, B. H., Morgan, M. J. & Franklin, K. B. J. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience 63, 289–294 (1994). · DOI
- Burkey, A. R., Carstens, E., Wenniger, J. J., Tang, J. & Jasmin, L. An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception. J. Neurosci. 16, 6612–6623 (1996). · DOI
- Tershner, S. A. & Helmstetter, F. J. Antinociception produced by μ-opioid receptor activation in the amygdala is partly dependent on activation of μ-opioid and neurotensin receptors in the ventral periaqueductal gray. Brain Res. 865, 17–26 (2000). · DOI
- Kiefel, J. M., Rossi, G. C. & Bodnar, R. J. Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624, 151–161 (1993). · DOI
- Roychowdhury, S. M. & Fields, H. L. Endogenous opioids acting at a medullary μ-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience 74, 863–872 (1996). · DOI
- Al-Rodhan, N., Chipkin, R. & Yaksh, T. L. The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala. Brain Res. 520, 123–130 (1990). · DOI
- Watkins, L. R., Young, E. G., Kinscheck, I. B. & Mayer, J. D. The neural basis of footshock analgesia: the role of specific ventral medullary nuclei. Brain Res. 276, 305–315 (1983). · DOI
- Levine, J. D., Gordon, N. C., Jones, R. T. & Fields, H. L. The narcotic antagonist naloxone enhances clinical pain. Nature 272, 826–827 (1978). The first direct evidence that endogenous opioids modulate pain in humans. The authors used dental postoperative pain as the measure of action of the opioid-mediated analgesia system. · DOI
- Fields, H. L. Is there a facilitating component to central pain modulation? APS J. 1, 139–141 (1992). · DOI
- Porreca, F., Ossipov, M. H. & Gebhart, G. F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319–325 (2002). · DOI · Paper page
- Urban, M. O. & Gebhart, G. F. Supraspinal contributions to hyperalgesia. Proc. Natl Acad. Sci. USA 96, 7687–7692 (1999). · DOI
- Zhuo, M. & Gebhart, G. F. Characterization of descending inhibition and facilitation from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Pain 42, 337–350 (1990). · DOI
- Zhuo, M. & Gebhart, G. F. Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. J. Neurophys. 67, 1599–1614 (1992). · DOI
- Urban, M. O., Coutinho, S. V. & Gebhart, G. F. Biphasic modulation of visceral nociception by neurotensin in rat rostral ventromedial medulla. J. Pharmacol. Exp. Ther. 290, 207–213 (1999).
- Watkins, L. R. et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639, 283–299 (1994). · DOI
- Morgan, M. M., Heinricher, M. M. & Fields, H. L. Inhibition and facilitation of different nocifensor reflexes by spatially remote noxious thermal stimuli. J. Neurophysiol. 72, 1152–1160 (1994). · DOI
- Haws, C. M., Williamson, A. M. & Fields, H. L. Putative nociceptive modulatory neurons in the dorsolateral pontomesencephalic reticular formation. Brain Res. 483, 272–282 (1989). · DOI
- Heinricher, M. M., Cheng, Z. F. & Fields, H. L. Evidence for two classes of nociceptive modulating neurons in the periaqueductal gray. J. Neurosci. 7, 271–278 (1987). · DOI
- Fields, H. L., Malick, A. & Burstein, R. Dorsal horn projection targets of on and off cells in the rostral ventromedial medulla. J. Neurophysiol. 74, 1742–1759 (1995). Microstimulation is used to track the terminals of on and off cells into dorsal horn laminae I, II and V. · DOI
- Heinricher, M. M., McGaraughty, S. & Farr, D. A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81, 57–65 (1999). · DOI
- Heinricher, M. M., McGaraughty, S. & Grandy, D. K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurophysiol. 78, 3351–3358 (1997). · DOI
- Heinricher, M. M., McGaraughty, S. & Tortorici, V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J. Neurophysiol. 85, 280–286 (2001). · DOI
- Morgan, M. M. & Fields, H. L. Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli. J. Neurophysiol. 72, 1161–1170 (1994). · DOI
- Porreca, F. et al. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expression the μ-opioid receptor. J. Neurosci. 21, 5281–5288 (2001). · DOI
- Gardell, L. R. et al. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J. Neurosci. 23, 8370–8379 (2003). · DOI
- Barbaro, N. M., Heinricher, M. M. & Fields, H. L. Putative nociceptive modulatory neurons in the rostral ventromedial medulla of the rat display highly correlated firing patterns. Somatosens. Motor Res. 6, 413–425 (1989). · DOI
- Heinricher, M. M., Barbaro, N. M. & Fields, H. L. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness. Somatosens. Motor Res. 6, 427–439 (1989). · DOI
- Heinricher, M. M. & McGaraughty, S. Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry. Pain 75, 247–255 (1998). · DOI
- Mason, P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu. Rev. Neurosci. 24, 737–777 (2001). · DOI
- Leung, C. G. & Mason, P. Physiological properties of raphe magnus neurons during sleep and waking. J. Neurophysiol. 81, 584–595 (1999). This study uses single unit recording in awake rats to demonstrate state dependence of firing patterns in on, off and neutral cells in the rostral ventromedial medulla. · DOI
- Akil, H., Meng, F., Devine, D. P. & Watson, S. J. Molecular and neuroanatomical properties of the endogenous opioid system: implications tor treatment of opiate addiction. Semin. Neurosci. 9, 70–83 (1997). · DOI
- Eguchi, M. Recent advances in selective opioid receptor agonists and antagonists. Med. Res. Rev. 24, 182–212 (2004). · DOI
- Bridge, K. E., Wainwright, A., Reilly, K. & Oliver, K. R. Autoradiographic localization of 125i[tyr14] nociceptin/orphanin FQ binding sites in macaque primate CNS. Neuroscience 118, 513–523 (2003). · DOI
- Pan, Z. Z., Williams, J. T. & Osborne, P. B. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J. Physiol. (Lond.) 427, 519–532 (1990). The first in vitro study of RVM neurons. The authors use sharp electrodes and demonstrate distinct populations of neurons that are either directly inhibited or disinhibited by opioid agonists. · DOI
- Heinricher, M. M., Morgan, M. M. & Fields, H. L. Direct and indirect action of morphine on medullary neurons that modulate nociception. Neuroscience 48, 533–543 (1992). · DOI
- Vaughan, C. W. & Christie, M. J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. (Lond.) 498, 463–472 (1997). · DOI
- Vaughan, C. W. et al. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol. 139, 362–367 (2003). · DOI
- Heinricher, M. M., Morgan, M. M., Tortorici, V. & Fields, H. L. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63, 279–288 (1994). · DOI
- Heinricher, M. M. & Tortorici, V. Interference with GABA transmission in the rostral ventromedial medulla: dishinhibition of off-cells as a central mechanism in nociceptive modulation. Neuroscience 63, 533–546 (1994). · DOI
- Finnegan, T. F., Li, D. P., Chen, S. R. & Pan, H. L. Activation of μ-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons. J. Pharmacol. Exp. Ther. 309, 476–483 (2004). · DOI
- Connor, M., Schuller, A., Pintar, J. E. & Christie, M. J. μ-Opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol. 126, 1553–1558 (1999). · DOI
- Heinricher, M. M. & Fields, H. L. in The Delta Receptor: Molecular and Effect of Delta Opioid Compounds (ed. Woods, J.) 467–480 (Marcel Dekker, New York, 2003).
- Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. μ- and δ-opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Research 665, 85–93 (1994). · DOI
- Ossipov, M. H., Kovelowski, C. J., Nichols, M. L., Hruby, V. J. & Porreca, F. Characterization of supraspinal antinociceptive actions of opioid δ agonists in the rat. Pain 62, 287–293 (1995). · DOI
- Connor, M. & Christie, M. J. Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J. Physiol. (Lond.) 509, 47–58 (1998). · DOI
- Kiefel, J. M., Rossi, G. C. & Bodnar, R. J. Medullary μ- and δ-opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624, 151–161 (1993). · DOI
- Hirakawa, N., Tershner, S. A. & Fields, H. L. Highly δ-selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO. Neuroreport 10, 3125–3129 (1999). · DOI
- Thorat, S. N. & Hammond, D. L. Modulation of nociception by microinjection of δ-1 and δ-2 opioid receptor ligands in the ventromedial medulla of the rat. J. Pharmacol. Exp. Ther. 283, 1185–1192 (1997).
- Harasawa, I., Fields, H. L. & Meng, I. D. δ-opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons. Pain 85, 255–262 (2000). · DOI
- Cahill, C. M., Morinville, A., Hoffert, C., O'Donnell, D. & Beaudet, A. Up-regulation and trafficking of δ-opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101, 199–208 (2003). · DOI
- Hurley, R. W. & Hammond, D. L. The analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammation. J. Neurosci. 20, 1249–1259 (2000). · DOI
- Vaughan, C. W., Ingram, S. L. & Christie, M. J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17, 996–1003 (1997). References 84—86 demonstrate the robust and promiscuous inhibition that is produced by orphanin in both PAG and RVM. · DOI
- Pan, Z., Hirakawa, N. & Fields, H. L. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26, 515–522 (2000). · DOI
- Vaughan, C. W. et al. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. J. Physiol. (Lond.) 534, 849–859 (2001). · DOI
- Darland, T., Heinricher, M. M. & Grandy, D. K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21, 215–221 (1998). · DOI
- Millan, M. J. κ-opioid receptor-mediated antinociception in the rat. I. Comparative actions of μ- and κ-opioids against noxious, thermal, pressure and electrical stimuli. J. Pharmacol. Exp. Ther. 251, 334–341 (1989).
- Millan, M. J., Czlonkowski, A., Lipkowski, A. & Herz, A. κ-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. J. Pharmacol. Exp. Ther. 251, 342–350 (1989).
- Pan, Z. Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol. Sci. 19, 94–98 (1998). · DOI
- Bederson, J. B., Fields, H. L. & Barbaro, N. M. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased ON-cell activity in the rostral ventromedial medulla. Somatosens. Motor Res. 7, 185–203 (1990). · DOI
- Kaplan, H. & Fields, H. L. Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J. Neurosci. 11, 1433–1439 (1991). · DOI
- Bandler, R. & Keay, K. A. in Progress in Brain Research Vol. 107 (eds Holstege, G., Bandler, R. & Saper, C.) 285–300 (Elsevier, Amsterdam, 1996).
- Fanselow, M. S. Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia. Ann. NY Acad. Sci. 467, 40–54 (1986). · DOI · Paper page
- Bolles, R. C. & Fanselow, M. S. A perceptual-defensive-recuperative model of fear and pain. Behav. Brain Sci. 3, 291–323 (1980). · DOI
- Johansen, J. P., Fields, H. L. & Manning, B. H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc. Natl Acad. Sci. USA 98, 8077–8082 (2001). · DOI
- Johansen, J. P. & Fields, H. L. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nature Neurosci. (in the press). · DOI
- Kavaliers, M. & Colwell, D. D. Sex differences in opioid and non-opioid mediated predator-induced analgesia in mice. Brain Res. 568, 173–177 (1991). · DOI
- Miczek, K. A. & Winslow, J. T. Analgesia and decrement in operant performance in socially defeated mice: selective cross-tolerance to morphine and antagonism by naltrexone. Psychopharmacology (Berl.) 92, 444–451 (1987). · DOI
- Bellgowan, P. S. F. & Helmstetter, F. J. The role of μ and κ-opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia. Brain Res. 791, 83–89 (1998). · DOI
- Helmstetter, F. J., Bellgowan, P. S. & Poore, L. H. Microinfusion of μ- but not δ- or κ-opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats. J. Pharmacol. Exp. Ther. 275, 381–388 (1995).
- Foo, H. & Helmstetter, F. J. Hypoalgesia elicited by a conditioned stimulus is blocked by a μ-, but not a δ- or a κ-opioid antagonist injected into the rostral ventromedial medulla. Pain 83, 427–431 (1999). · DOI
- Foo, H. & Helmstetter, F. J. Activation of κ-opioid receptors in the rostral ventromedial medulla blocks stress-induced antinociception. Neuroreport 11, 3349–3352 (2000). · DOI
- Blass, E., Fitzgerald, E. & Kehoe, P. Interactions between sucrose, pain and isolation distress. Pharmacol. Biochem. Behav. 26, 483–489 (1987). · DOI
- Bucher, H. U. et al. Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatr. Res. 38, 332–335 (1995). · DOI
- Dutta, R., Mukherjee, K. & Mathur, R. Effect of VMH lesion on sucrose-fed analgesia in formalin pain. Jpn J. Physiol. 51, 63–69 (2001). · DOI
- Dum, J. & Herz, A. Endorphinergic modulation of neural reward systems indicated by behavioral changes. Pharmacol. Biochem. Behav. 21, 259–266 (1984). The authors show that rats conditioned to expect sucrose when they are placed on a hot plate will show elevated escape thresholds. This analgesic effect is blocked by the opioid antagonist naloxone. · DOI
- Schmidt, B. L., Tambeli, C. H., Levine, J. D. & Gear, R. W. μ/δ Cooperativity and opposing κ-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur. J. Neurosci. 15, 861–868 (2002). · DOI
- Kelley, A. E. et al. Opioid modulation of taste hedonics within the ventral striatum. Physiol. Behav. 76, 365–377 (2002). · DOI
- Benedetti, F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64, 535–543 (1996). · DOI
- Grevert, P. & Goldstein, A. in Placebo: Theory, Research and Mechanisms (eds White, L., Tursky, B. & Shwartz, G. E.) 332–350 (The Guilford Press, New York, 1985).
- Price, D. D. et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83, 147–156 (1999). · DOI
- Montgomery, G. H. & Kirsch, I. Classical conditioning and the placebo effect. Pain 72, 107–113 (1997). · DOI · Paper page
- Amanzio, M. & Benedetti, F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J. Neurosci. 19, 484–494 (1999). · DOI · Paper page
- de la Fuente-Fernandez, R., Schulzer, M. & Stoessl, A. J. The placebo effect in neurological disorders. Lancet Neurol. 1, 85–91 (2002). · DOI · Paper page
- Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. Placebo and opioid analgesia — imaging a shared neuronal network. Science 295, 1737–1740 (2002). Using positron emission tomography, the authors show extensive overlap between brain areas that are activated by the short-acting MOR agonist remifentanyl and a placebo manipulation that produces analgesia. · DOI · Paper page
- Wager, T. D. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303, 1162–1167 (2004). · DOI · Paper page
- An, X., Bandler, R., Ongur, D. & Price, J. L. Prefrontal cortical projections to longitudinal columns in the midbrain periaqueductal gray in macaque monkeys. J. Comp. Neurol. 401, 455–479 (1998). · DOI · Paper page
- Kirsch, P. et al. Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system: an event-related fMRI study. Neuroimage 20, 1086–1095 (2003). · DOI
- Shidara, M. & Richmond, B. J. Anterior cingulate: single neuronal signals related to degree of reward expectancy. Science 296, 1709–1711 (2002). · DOI
- Kunishio, K. & Haber, S. N. Primate cingulostriatal projection: limbic striatal versus sensorimotor striatal input. J. Comp. Neurol. 350, 337–356 (1994). · DOI
- Becerra, L., Breiter, H. C., Wise, R., Gonzalez, R. G. & Borsook, D. Reward circuitry activation by noxious thermal stimuli. Neuron 32, 927–946 (2001). · DOI
- Suzuki, R., Morcuende, S., Webber, M., Hunt, S. P. & Dickenson, A. H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neurosci. 5, 1319–1326 (2002). · DOI
- Le Bars, D. in Serotonin and Pain (eds Osborne, N. M. & Hamon, M.) 171–226 (John Wiley, New York, 1988).
- Potrebic, S. B., Fields, H. L. & Mason, P. Serotonin immunoreactivity is contained in one physiological cell class in the rat rostral ventromedial medulla. J. Neurosci. 14, 1655–1665 (1994). Using in vivo intracellular recording, on, off and neutral cells were identified physiologically and filled with biocytin for later immunocytochemistry. Serotonin was only found in neutral cells. · DOI
- Marinelli, S., Vaughan, C. W., Schnell, S. A., Wessendorf, M. W. & Christie, M. J. Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J. Neurosci. 22, 10847–10855 (2002). The authors use a marker injected into the spinal cord and transported retrogradely to identify spinally projecting RVM neurons. They show that a significant number of spinally-projecting serotonergic neurons express functional μ- and κ-opioid receptors. · DOI
- Mason, P. & Gao, K. Raphe magnus serotonergic neurons tonically modulate nociceptive transmission. Pain Forum 7, 143–150 (1998). · DOI
- Huang, L. -Y. M. Tonic release of serotonin. Pain Forum 7, 151–154 (1998). · DOI
- Yaksh, T. L. & Wilson, P. R. Spinal serotonin system mediates antinociception. J. Pharmacol. Exp. Ther. 208, 446–453 (1979).
- Zhuo, M. & Gebhart, G. F. Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res. 550, 35–48 (1991). · DOI
- Calejesan, A. A., Chang, M. H. & Zhuo, M. Spinal serotonergic receptors meidate facilitation of a nociceptive reflex by subcutaneous formalin inejction into the hindpaw in rats. Brain Res. 798, 46–54 (1998). · DOI
- Green, G. M., Scarth, J. & Dickenson, A. An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT3 receptors in the anaesthetized rat. Pain 89, 81–88 (2000). · DOI
Cited by
Sorted by citations
Items 301–400 of 805
Pain-facilitating medullary neurons contribute to opioid-induced respiratory depression
Phillips, R. S., Cleary, D. R., Nalwalk, J. W., Arttamangkul, S., Hough, L. B., & Heinricher, M. M. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00563.2012 · Cited by 50
“This system is the driving force behind the natural 73 suppression or enhancement of pain in different behavioral states (Fields 2004).”
BackgroundStructural Brain Changes Related to Disease Duration in Patients with Asthma
von Leupoldt, A., Brassen, S., Baumann, H., Klose, H., & Büchel, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023739 · Cited by 43
“These alterations in a brain structure with a well documented role in the antinociception of pain [30,31] and in fear and defence behaviour [32], are therefore likely to contribute to the blunted perception of dyspnea at least in subgroups of patients with asthma.”
BackgroundZhang, L., Sykes, K. T., Buhler, A., & Hammond, D. L. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00883.2005 · Cited by 43
“…and colleagues used extracellular recording methods to characterize the responses of RVM neurons to noxious stimuli in vivo and proposed that RVM neurons can be assigned to one of three functional classes, termed ON, OFF, and NEUTRAL cells (Fields 2004; Fields et al. 1983; Vanegas et al. 1984).”
BackgroundResultUnderstanding Neuropathic Pain
Zieglgänsberger, W., Berthele, A., & Tölle, T. R. (2005) · CNS Spectrums · doi:10.1017/s1092852900022628 · Cited by 69
Khasabov, S., Ghilardi, J. R., Mantyh, P., & Simone, D. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01160.2003 · Cited by 43
Combination Drug Therapy for the Management of Chronic Neuropathic Pain
Boccella, S., Filippis, L. D., Giorgio, C., Brandolini, L., Jones, M., Novelli, R., Amorizzo, E., Leoni, M. L. G., Terranova, G., Maione, S., et al. (2023) · Biomolecules · doi:10.3390/biom13121802 · Cited by 41
“Nonsteroidal anti-inflammatory drugs (NSAIDS), or nonselective cyclo-oxygenase-1/2 (COX1/2) inhibitors, as well as selective COX2 inhibitors, are also commonly used to manage inflammation and pain in NP, particularly in sub-acute and acute-on-chronic phases [34,35].”
BackgroundA new concept affecting restoration of inflammation-reactive astrocytes.
Block, L., Björklund, U., Westerlund, A., Jörneberg, P., Biber, B., & Hansson, E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.033 · Cited by 42
“The classical opioid system is best known for its effects on nociception (Fields, 2004); however, it is also important for modulating the immune system and releasing Ca2+ from intracellular stores.”
Clonidine maintains intrathecal self-administration in rats following spinal nerve ligation
Martin, T. J., Kim, S. A., & Eisenach, J. C. (2006) · Pain · doi:10.1016/j.pain.2006.05.027 · Cited by 40
“These different determinants of drug self-administration may blur in that they reflect similar central mechanisms (Fields, 2004).”
BackgroundDosSantos, M. F. H., Oliveira, A. T., Ferreira, N. R., Carvalho, A. C. P., & Rosado-de-Castro, P. H. (2018) · Pain Research and Management · doi:10.1155/2018/2368386 · Cited by 44
“Remarkably, it has also been reported that the connectivity between ventral striatum and PFC predicts the prognosis of chronic pain [59], and (4) all cortical inputs converge to the PAG-RVM-spinal cord, which facilitates or inhibits nociception [46, 54].”
BackgroundInfluentialKoshimizu, T., Honda, K., Nagaoka-Uozumi, S., Ichimura, A., Kimura, I., Nakaya, M., Sakai, N., Shibata, K., Ushijima, K., Fujimura, A., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0144-y · Cited by 43
Supraspinal Peroxynitrite Modulates Pain Signaling by Suppressing the Endogenous Opioid Pathway
Little, J. W., Chen, Z., Doyle, T. M., Porreca, F., Ghaffari, M., Bryant, L., Neumann, W. L., & Salvemini, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6345-11.2012 · Cited by 42
“The importance of endogenous ENK signaling in RVM descending inhibition is in agreement with previous work (al-Rodhan et al., 1990; Fields, 2004).”
ResultRuggieri, V., Vitale, G., Pini, L. A., & Sandrini, M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0284-9 · Cited by 36
“Indeed, the interaction of opioid and serotonin systems in producing analgesia has been widely demonstrated over several years (Watkins and Mayer 1986; Lipp 1991 )t hrough the regulation of centralμ and κ receptors ( Fields 2004 ).”
BackgroundBradaïa, A., Berton, F., Ferrari, S., & Lüscher, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406632102 · Cited by 37
The Downregulation of Opioid Receptors and Neuropathic Pain
Li, L., Chen, J., & Li, Y.-Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065981 · Cited by 46
“Opioid receptors can inhibit multiple levels of the ascending pain pathways for pain signal transmission in supraspinal regions related to nociceptive message integration and participate in facilitatory and inhibitory descending pathways [13,38,39].”
BackgroundMode of action of astrocytes in pain: From the spinal cord to the brain
Chen, Y.-L., Feng, X., Cheung, C., & Liu, J. A. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102365 · Cited by 44
Caffeine and Primary (Migraine) Headaches—Friend or Foe?
Alstadhaug, K. B., & Andreou, A. P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01275 · Cited by 52
“These neurons give rise to the main ascending trigeminothalamic pathway that carries sensory information to third order neurons in the thalamus, before processing the information to higher cortical areas (115).”
BackgroundAmygdala functional connectivity is reduced after the cold pressor task
Clewett, D., Schoeke, A., & Mather, M. (2013) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-013-0162-x · Cited by 41
Mathes, W. F., & Kanarek, R. B. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.020 · Cited by 34
Serotonin in Pain and Pain Control
Sommer, C. (2010) · doi:10.1016/s1569-7339(10)70096-5 · Cited by 40
Aby, F., Lorenzo, L.-É., Grivet, Z., Bouali‐Benazzouz, R., Martin, H., Valério, S., Whitestone, S., Isabel, D., Idi, W., Bouchatta, O., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0689 · Cited by 47
“Recent studies have identified specific neural circuits in the PAG and the RVM promoting either pain inhibition or pain facilitation ( 13 – 17 ).”
InfluentialChen, Q., & Heinricher, M. M. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.932476 · Cited by 44
“Stress-induced analgesia was an important stimulus to research in the latter half of the twentieth century: excitement was in part because delineation of the circuitry mediating stress-induced analgesia demonstrated the existence of an intrinsic capacity to modulate pain, and also because this same circuitry was disco…”
BackgroundApplications of dynamic functional connectivity to pain and its modulation
Necka, E. A., Lee, I., Kucyi, A., Cheng, J. C., Yu, Q., & Atlas, L. Y. (2019) · PAIN Reports · doi:10.1097/pr9.0000000000000752 · Cited by 44
Evidence for a spinal involvement in temporal pain contrast enhancement
Sprenger, C., Stenmans, P., Tinnermann, A., & Büchel, C. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.09.003 · Cited by 40
“Traditionally, the various forms of endogenous pain modulation have been viewed as a set of regulatory mechanisms that enable the organism to inhibit or amplify nociceptive signals pursuant to internal or environmental biological needs (Basbaum et al., 2009; Fields, 2004; Millan, 2002).”
Wei, S., Chen, L., Lin, M., Li, W., Low, I., Yang, C., Chao, H., & Hsieh, J. (2017) · Scientific Reports · doi:10.1038/srep39906 · Cited by 43
A Novel Role for the Periaqueductal Gray in Consummatory Behavior
Tryon, V. L., & Mizumori, S. J. Y. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00178 · Cited by 34
“Indeed, evidence shows that opioid-mediated pain circuits are activated during appetitive circumstances (Fields, 2004).”
BackgroundCerritelli, S., Hirschberg, S., Hill, R. W., Balthasar, N., & Pickering, A. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153187 · Cited by 41
“One of the best characterised of these peptides, β-endorphin [6], has been shown to play roles in endogenous analgesia and stress responses [7] as well as being linked to reward processing [8], feeding [9] and cardiorespiratory regulation [10].”
BackgroundInfluentialStriatal opioid receptor availability is related to acute and chronic pain perception in arthritis
Brown, C. A., Matthews, J. C., Fairclough, M., McMahon, A. W., Barnett, E., Al-Kaysi, A., El‐Deredy, W., & Jones, A. K. P. (2015) · Pain · doi:10.1097/j.pain.0000000000000299 · Cited by 39
“the release of endogenous opioid peptides and subsequent agonism of OpRs in the central nervous system.(19) However,”
BackgroundResolving the Delusion Paradox
Petrović, P., & Sterzer, P. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad084 · Cited by 45
Pedersen, N., Vaughan, C., & Christie, M. (2011) · Journal of Neurophysiology · doi:10.1152/jn.01062.2010 · Cited by 37
“-opioid receptor; raphe magnus; -aminobutyric acid; glutamate decarboxylase THE ROSTRAL VENTROMEDIAL MEDULLA (RVM) forms part of a descending pathway that is an important site for the supraspinal antinociceptive actions of opioids (Fields 2004).”
BackgroundEnhancement of offset analgesia during sequential testing
Derbyshire, S. W. G., & Osborn, J. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.01.008 · Cited by 36
“Grill and Coghill (2002) also suggest central mechanisms play a role in offset analgesia and imply that the effect is due to activation of central inhibitory mechanisms such as descending influence from the periaqueductal grey (PAG) via the rostral ventromedial medulla (RVM) (Budai et al., 1998; Fields, 2004; Tracey a…”
BackgroundInfluentialThe neural processes of acquiring placebo effects through observation
Schenk, L. A., & Colloca, L. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116510 · Cited by 51
Colloca, L., Wang, Y., Martinez, P. E., Chang, Y.-P. C., Ryan, K. A., Hodgkinson, C. A., Goldman, D. A., & Dorsey, S. G. (2019) · Pain · doi:10.1097/j.pain.0000000000001578 · Cited by 49
“The opioid system plays a relevant role in driving placebo effects as demonstrated by pharmacological and imaging studies.(2,21,23,34,48,49) Peciña and colleagues first examined the”
BackgroundKim, J., Gangadharan, G., Byun, J., Choi, E., Lee, C. J., & Shin, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806082115 · Cited by 39
“The most investigated form of the physiological activation of opioid-linked pain-modulating circuits originates under the general framework of stress-induced analgesia (7, 46).”
BackgroundA neural mechanism of direct and observational conditioning for placebo and nocebo responses
Tu, Y., Park, J., Ahlfors, S. P., Khan, S., Egorova, N., Lang, C., Cao, J., & Kong, J. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.10.020 · Cited by 47
“Studies suggest that the endogenous opioid system is essential for both placebo and nocebo effects (Amanzio and Benedetti, 1999; Benedetti et al., 1999; Fields, 2004; Petrovic et al., 2002).”
BackgroundRütgen, M., Seidel, E., Pletti, C., Riečanský, I., Gartus, A., Eisenegger, C., & Lamm, C. (2017) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.04.023 · Cited by 40
“Then, we investigated whether pharmacologically blocking opioidergic activity (with an opioid receptor antagonist), which is one of the main neurochemical mechanisms of placebo analgesia and also plays a central role in pain and its regulation (Fields, 2004 for review), would revert these effects.”
Spotlight on pain: optogenetic approaches for interrogating somatosensory circuits
Copits, B. A., Pullen, M. Y., & Gereau, R. W. (2016) · Pain · doi:10.1097/j.pain.0000000000000620 · Cited by 37
“The rostral ventral medulla (RVM) contains another family of neuromodulatory neurons in the brainstem that send descending serotonergic projections to the spinal cord.(11,48,81) However, serotonin has both excitatory and inhibitory effects in the dorsal horn, and electrical stimulation of the RVM produced both pronoci…”
BackgroundThe µ-opioid system promotes visual attention to faces and eyes
Chelnokova, O., Laeng, B., Løseth, G. E., Eikemo, M., Willoch, F., & Leknes, S. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw116 · Cited by 37
“The m-opioid receptor (MOR) system, central to reward and pain regulation across species (Fields, 2004), is also important for social reward such as bonding behaviors in rodents and primates (Herman and Panksepp, 1978; Panksepp, 1980; Moles et al., 2004; Machin and Dunbar, 2011; Løseth et al.,…”
BackgroundFentanyl, an agonist at the mu opioid receptor, depresses pupillary unrest
Bokoch, M. P., Behrends, M., Neice, A. E., & Larson, M. D. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.01.004 · Cited by 40
“A possibly similar model of opioidinduced disinhibition is the opioid effects on the supraspinal analgesic pathway (Fields, 2004).”
BackgroundTao, W., Chen, Q., Zhou, W., Wang, Y., Wang, L., & Zhang, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580381 · Cited by 37
“It plays an important role in the development and maintenance of the behavioral state of sensitized pain and opioid analgesia under chronic pain conditions (45, 46).”
BackgroundCentral Pain Modulation and Scalp Tenderness in Frequent Episodic Tension‐Type Headache
Drummond, P. D., & Knudsen, L. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01779.x · Cited by 34
Feng, M., Zhang, Y., Wen, Z., Hou, X., Ye, Y., Fu, C., Luo, W., & Liu, B. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.778139 · Cited by 39
“As well known, the DPMS played an essential role in pain modulation and the physiopathology of chronic pain (Fields, 2004; Borsook and Burstein, 2012; Ossipov et al., 2014).”
BackgroundNeuropathic pain modeling: Focus on synaptic and ion channel mechanisms
Bouali‐Benazzouz, R., Landry, M., Benazzouz, A., & Fossat, P. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102030 · Cited by 40
Pain in neuropsychiatry: Insights from animal models
Bravo, L., Llorca-Torralba, M., Suárez‐Pereira, I., & Berrocoso, E. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.029 · Cited by 41
Buehlmann, D., Ielacqua, G. D., Xandry, J., & Rudin, M. (2018) · Pain · doi:10.1097/j.pain.0000000000001388 · Cited by 36
An Introduction to Pain Pathways and Pain “Targets”
Das, V. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.01.003 · Cited by 44
The neurobiology of social loss in animals: Some keys to the puzzle of psychic pain in humans.
Panksepp, J. (2010) · American Psychological Association eBooks · doi:10.1037/12351-001 · Cited by 33
ThermoTRP channels in pain sexual dimorphism: new insights for drug intervention
Cabañero, D., Villalba‐Riquelme, E., Fernandez-Ballester, G. J., Fernández-Carvajal, A. M., & Ferrer-Montiel, A. V. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108297 · Cited by 35
Functional integration of a serotonergic neuron in the Drosophila antennal lobe
Zhang, X., & Gaudry, Q. (2016) · eLife · doi:10.7554/elife.16836 · Cited by 54
Emotional modulation of experimental pain: a source imaging study of laser evoked potentials
Stančák, A., & Fallon, N. B. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00552 · Cited by 31
“The late positive potential has negative maximum in the parieto-occipital and positive maximum in frontal and central electrodes (Foti et al., 2009), which map was similar to the topographic map shown in Figure 4A in our study.”
BackgroundMethodResultInfluentialRSK2 Signaling in Medial Habenula Contributes to Acute Morphine Analgesia
Darcq, E., Befort, K., Koebel, P., Pannetier, S., Mahoney, M. K., Gavériaux‐Ruff, C., Hanauer, A., & Kieffer, B. L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.316 · Cited by 37
“…at the level of first-order primary afferent neurons and extend to higher-order thalamic and cortical levels where pain messages are integrated, as well as descending inhibitory pain pathways, which recruit mainly brain stem and spinal cord networks (Fields, 2004; Dickenson and Kieffer, 2006).”
BackgroundZhang, L. N., & Hammond, D. L. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91337.2008 · Cited by 33
Caram-Salas, N. L., Reyes-García, G., Bartoszyk, G., Araiza-Saldaña, C. I., Ambriz‐Tututi, M., Rocha-González, H. I., Arreola-Espino, R., Cruz, S., & Granados-Soto, V. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.034 · Cited by 33
“Moreover, it has been suggested that these actions may lead to analgesia via presynaptic desinhibitory mechanisms (Porreca et al., 2002; Vaughan et al., 2003; Fields, 2004).”
BackgroundGabel, F., Hovhannisyan, V., Andry, V., & Goumon, Y. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15792 · Cited by 37
“Upon activation, these Class A GPCRs induce a strong hyperpolarisation of MOR-expressing neurons and inhibit the transmission of nociceptive signals (Fields, 2004).”
BackgroundModulation of trigeminovascular processing: Novel insights into primary headache disorders
Holland, P. (2009) · Cephalalgia · doi:10.1177/03331024090290s302 · Cited by 32
The Neural Bases of Placebo Effects in Pain
Wager, T. D. (2005) · Current Directions in Psychological Science · doi:10.1111/j.0963-7214.2005.00359.x · Cited by 50
“Since some have argued that analgesia may be a special case of reward processing—pain relief may be thought to be rewarding in and of itself (Fields 2004; Irizarry and Licinio 2005)—researchers have been interested in examining the contributions of dopamine systems to placebo analgesia.”
BackgroundResultInfluentialBie, B., & Pan, Z. Z. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-7 · Cited by 31
Altered functional connectivity between hypothalamus and limbic system in fibromyalgia
Kong, J., Huang, Y., Liu, J., Yu, S., Cheng, M. S., Chen, H., Wilson, G., Harvey, W. F., Li, W., & Wang, C. (2021) · Molecular Brain · doi:10.1186/s13041-020-00705-2 · Cited by 35
Garland, E. L. (2020) · Pain · doi:10.1097/j.pain.0000000000001988 · Cited by 36
“When the decision to avoid potential injury is outweighed by the motivation to pursue a conflicting goal (eg, a significant reward), top–down processes in the brain inhibit nociception through release of opioid peptides; conversely, if the decision is to ignore the conflicting goal and instead to respond to the noxiou…”
BackgroundNo pain, no social gains: A social-signaling perspective of human pain behaviors
Vigil, J. M. (2014) · World Journal of Anesthesiology · doi:10.5313/wja.v3.i1.18 · Cited by 30
Ikeda, H., Takasu, S., & Murase, K. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-14 · Cited by 27
“In rats, it was found to decrease the stress-induced behavioral effects and to decrease the pentobarbital sleeping time [20,21].”
BackgroundA nonopioid analgesic acts upon the PAG‐RVM axis to reverse inflammatory hyperalgesia
Vázquez, E., Escobar, W., Ramirez, K., & Vanegas, H. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05280.x · Cited by 25
“The antinociceptive function of the PAG is conveyed to the spinal cord largely by way of the RVM (Fields, 2004), and in models of acute pain the action of metamizol upon PAG triggers”
BackgroundArrestins - Pharmacology and Therapeutic Potential
Gurevich, V. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-41199-1 · Cited by 31
The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia
Lubejko, S. T., Graham, R., Livrizzi, G., Schaefer, R., Banghart, M. R., & Creed, M. C. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1044686 · Cited by 35
“However, the δ- and κ-opioid receptors (DORs and KORs) are also important in pain modulation (Fields, 2004; Corder et al., 2018).”
BackgroundEffect of Expectation on Pain Processing: A Psychophysics and Functional MRI Analysis
Henderson, L. A., Pietro, F. D., Youssef, A. M., Lee, S., Tam, S., Akhter, R., Mills, E. P., Murray, G. M., Peck, C. C., & Macey, P. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00006 · Cited by 33
“…incoming noxious inputs via projections to the rostral ventromedial medulla, a region which contains “ON” and “OFF” cells that can increase and decrease the excitability of neurons in the dorsal horn, respectively (Fields et al., 1983; Fields, 2004; Hellman and Mason, 2012; Salas et al., 2016).”
BackgroundBüchel, C. (2023) · eLife · doi:10.7554/elife.81795 · Cited by 37
“In addition, network analyses have revealed that expectation effects are mirrored by changes in coupling in the descending pain modulatory system (Porreca et al., 2002; Fields, 2004; Tracey and Dunckley, 2004), in particular between the mPFC and the periaqueductal gray (PAG) (Bingel et al.”
BackgroundHierarchical predictive coding in distributed pain circuits
Chen, Z. S. (2023) · Frontiers in Neural Circuits · doi:10.3389/fncir.2023.1073537 · Cited by 35
“Several reviews have discussed these pain pathways in detail (Millian, 2002; Fields, 2004; Vogt, 2005).”
BackgroundEngaging endogenous opioid circuits in pain affective processes
Kimmey, B. A., McCall, N. M., Wooldridge, L. M., Satterthwaite, T. D., & Corder, G. F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24762 · Cited by 31
“Thus, top-down endogenous opioid-enriched circuits modulate pain experience and can be triggered by conditioned or learned associations between an intervention and its purported analgesic properties (Fields, 2004).”
BackgroundSardi, N. F., Lazzarim, M. K., Guilhen, V. A., Marcílio, R. S., Natume, P., Watanabe, T., Lima, M. M. S., Tobaldini, G., & Fischer, L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.022 · Cited by 35
“…NAc for two reasons; first, both vlPAG (Fields, 2004; Reynolds, 1969) and NAc core (Gear et al., 1999; Gear and Levine, 2011; Tobaldini et al., 2014) have key roles in pain modulation. vlPAG for example, controls the descending pain modulation system in an opioid dependent manner (Fields, 2004).”
BackgroundMethodInfluentialState of the Art: Novel Applications for Cortical Stimulation
Ridder, D. D., Perera, S., & Vanneste, S. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12593 · Cited by 32
“Functional connectivity analysis showed significant correlation between pgACC and PAG, basal ganglia, and lower pons activities, in other words the descending pain inhibitory pathway (107,108)”
BackgroundEconomic and clinical burden of opioid-induced nausea and vomiting
Nicholson, B. D. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2017.1243004 · Cited by 28
“surveys have reported that to reduce AEs associated with opioid treatment, specifically gastrointestinal (GI)-related AEs, patients often discontinue their opioid treatment [20,23,24].”
BackgroundTobaldini, G., Aisengart, B., Lima, M. S., Tambeli, C. H., & Fischer, L. (2014) · Journal of Pain · doi:10.1016/j.jpain.2013.12.008 · Cited by 29
Effects of Music Engagement on Responses to Painful Stimulation
Bradshaw, D. H., Chapman, C. R., Jacobson, R. C., & Donaldson, G. W. (2012) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318236c8ca · Cited by 30
“Appetitive motivation may activate descending pain inhibitory pathways.(42) Evidence suggests that cognitive distraction tasks during noxious stimulation increase activity in the periacqueductal gray region of the midbrain, an area associated with inhibition of sensory processing of noxious signals.”
BackgroundRegulation of G protein‐coupled receptor trafficking
Xu, Z., Zhang, X., & Scott, L. (2007) · Acta Physiologica · doi:10.1111/j.1365-201x.2007.01695.x · Cited by 29
Contribution of brainstem GABAA synaptic transmission to morphine analgesic tolerance
Ma, J., & Pan, Z. Z. (2006) · Pain · doi:10.1016/j.pain.2006.01.031 · Cited by 31
“NRM cells that lack MOR, or primary cells, are likely responsible for analgesic opioid-activated descending pain inhibition (Pan et al., 1997, 2000; Fields, 2004).”
BackgroundHaghparast, A., Naderi, N., Khani, A., Lashgari, R., & Motamedi, F. (2010) · Journal of Pain · doi:10.1016/j.jpain.2009.05.005 · Cited by 29
Bai, Y., Pacheco‐Barrios, K., Pacheco-Barrios, N. V., Liang, G., & Fregni, F. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00235-z · Cited by 34
Sprenger, C., Eichler, I.-C., Eichler, L., Zöllner, C., & Büchel, C. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2496-17.2018 · Cited by 30
“Altered functional connectivity in the descending pain-modulatory system predicts remifentanil offset-related increase in pain sensitivity As -opioid receptor agonists unfold part of their analgesic properties by acting on the pain-modulatory system (Barton et al., 1980; Fields, 2004; Haghparast et al., 2008), changin…”
BackgroundInfluentialThe role of cognitive reappraisal in placebo analgesia: an fMRI study
van der Meulen, M., Kamping, S., & Anton, F. (2017) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsx033 · Cited by 27
“The demonstration of increased connectivity between DLPFC and PAG in our study is in line with the idea that prefrontal mechanisms trigger pain control systems descending from the brainstem (Basbaum and Fields, 1984; Fields, 2004).”
ResultManagement of Chronic Visceral Pain
Olesen, A. E., Farmer, A. D., Olesen, S. S., Aziz, Q., & Drewes, A. M. (2016) · Pain Management · doi:10.2217/pmt-2015-0011 · Cited by 28
Madasu, M. K., Roche, M., & Finn, D. P. (2015) · Modern trends in psychiatry · doi:10.1159/000435934 · Cited by 29
Masaoka, Y., Takayama, M., Yajima, H., Kawase, A., Takakura, N., & Homma, I. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/921802 · Cited by 34
“A previous study showed that expectancies reduce stress and pain [17], which may be mediated by activation of the endogenous opiate system that is a part of the descending pain-modulating networks, as is the casewith placebo analgesia engendered by cognitive and motivational factors [18].”
BackgroundPharmacologic therapy for cough.
Young, E. C., & Smith, J. (2011) · Current opinion in pharmacology (Print) · doi:10.1016/j.coph.2011.06.003 · Cited by 28
Neuroimaging Studies of Primary Dysmenorrhea
Low, I., Wei, S., Lee, P.-S., Li, W., Lee, L.-C., Hsieh, J., & Chen, L. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1756-9_16 · Cited by 27
Shen, S., Wu, C., Lin, G., Yang, X., Zhou, Y., Zhao, C. S., Miao, Z., Tian, X., Wang, K., Yang, Z., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321532121 · Cited by 34
Han, J. J., Ridder, D. D., Vanneste, S., Chen, Y., Koo, J., & Song, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00410 · Cited by 26
“That is, when performing spinal cord stimulation, the amount of improvement depends on the activation of the pgACC (Moens et al., 2012), which is part of the descending pain inhibitory pathway (Fields, 2004; Kong et al., 2010), the somatosensory analog of the noise canceling system.”
BackgroundPahng, A. R., Paulsen, R. I., McGinn, M. A., Edwards, K. N., & Edwards, S. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.055 · Cited by 29
Are 10 kHz Stimulation and Burst Stimulation Fundamentally the Same?
Ridder, D. D., Perera, S., & Vanneste, S. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12614 · Cited by 28
“Pain is processed by at least three pathways, two ascending pain generating pathways (4,5) and at least one descending pain inhibitory pathway (6).”
BackgroundDissociable Neural Mechanisms Underlying the Modulation of Pain and Anxiety? An fMRI Pilot Study
Wiech, K., Edwards, R. R., Moseley, G. L., Berna, C., Ploner, M., & Tracey, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110654 · Cited by 29
“rACC and PAG are part of the descending pain control system that modulates spinal transmission of nociceptive information predominantly via opioidergic transmission [39].”
BackgroundSensitivity of quantitative sensory models to morphine analgesia in humans
Olesen, A. E., Brock, C., Sverrisdóttir, E., Larsen, I. M., & Drewes, A. M. (2014) · Journal of Pain Research · doi:10.2147/jpr.s73044 · Cited by 31
“21”
Hansson, E. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1363-6 · Cited by 27
Understanding cough and its management in lung cancer
Harle, A. S. M., Blackhall, F. H., Smith, J. A., & Molassiotis, A. (2012) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328352b6a5 · Cited by 29
“It may be that opiates and gabapentin exert their antitussive action by potentiating these pathways [20].”
BackgroundZhang, Z., & Pan, Z. Z. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.076307 · Cited by 26
“…the detailed signaling cascades responsible for DOR inhibition of GABA neurotransmission and for DOR-mediated behavioral antinociception in brainstem neurons of the nucleus raphe magnus (NRM), an important supraspinal structure for opioid modulation of pain (Pan et al., 1997; Fields, 2004).”
BackgroundInfluentialHaghparast, A., Soltani-Hekmat, A., Khani, A., & Komaki, A. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.003 · Cited by 27
A cholinergic circuit that relieves pain despite opioid tolerance
Sullere, S., Kunczt, A., & McGehee, D. S. (2023) · Neuron · doi:10.1016/j.neuron.2023.08.017 · Cited by 30
“14,15 The ventrolateral periaqueductal gray (vlPAG) is a key regulator of this pathway, 16 and electrical, 17–24 pharmacological, 17,19,25–33 and chemogenetic 14,34–36 manipulation of this region produces profound analgesia. vlPAG is also a key site of endorphin-mediated analgesia, 22 and direct…”
BackgroundThe Role of The Rostral Ventromedial Medulla in Stress Responses
Pagliusi, M., & Gomes, F. V. (2023) · Brain Sciences · doi:10.3390/brainsci13050776 · Cited by 28
Sun, N., Yu, L., Gao, Y., Ma, L., Ren, J., Liu, Y., Gao, D. S., Xie, C., Wu, Y., Wang, L., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.743207 · Cited by 26
“Despite their risks, opioids, such as morphine, are the main treatment option for neuropathic pain, but have limited effectiveness in patients with this debilitating disorder (Fields, 2004; Cooper et al., 2017; Els et al., 2017; Martinez-Navarro et al., 2018).”
BackgroundMechanism underlying starvation-dependent modulation of olfactory behavior in Drosophila larva
Slankster-Schmierer, E., Kollala, S. S., Baria, D., Dailey-Krempel, B., Jain, R., Odell, S. R., & Mathew, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-60098-z · Cited by 29
Khasabov, S. G., Malecha, P. W., Noack, J., Tabakov, J., Giesler, G. J., & Simone, D. A. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00478.2017 · Cited by 27
Volume expansion of periaqueductal gray in episodic migraine: a pilot MRI structural imaging study
Chen, Z., Chen, X., Liu, M., Liu, S., Ma, L., & Yu, S. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0797-z · Cited by 28
“PAG could exert a dual control, including inhibition and facilitation, on nociceptive transmission in the dorsal horn and trigeminal nucleus [8] by descending PAG-RVM (rostral ventromedial medulla) pathway contributing to central sensitization and development of secondary hyperalgesia [8, 9].”
BackgroundVisions on the future of medical devices in spinal cord stimulation: what medical device is needed?
Ridder, D. D., & Vanneste, S. (2015) · Expert Review of Medical Devices · doi:10.1586/17434440.2016.1136560 · Cited by 29
Metadata
- Authors
- Fields, H.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Fields, Howard
- ORCID
- Fields, Howard
- Venue
- Nature Reviews Neuroscience
- Published
- 2004-07
- Volume
- 5
- Issue
- 7
- Pages
- 565-575
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2030751218
- Cited by
- 946
- References
- 0
- Citations by year
- 2026: 46 · 2025: 43 · 2024: 36 · 2023: 42 · 2022: 54 · 2021: 52 · 2020: 38 · 2019: 43 · 2018: 49 · 2017: 66 · 2016: 45 · 2015: 39 · 2014: 48 · 2013: 47 · 2012: 56
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- opioid analgesia, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, motivational states, aversive motivation, appetitive motivation, pain transmission, pain modulation, opioid use disorder, choice behavior
- MeSH terms
- Analgesics, Opioid, Animals, Behavior, Animal, Humans, Medulla Oblongata, Models, Neurological, Motivation, Opioid-Related Disorders, Neural Pathways, Neurons, Nociceptors, Pain, Receptors, Opioid, Reinforcement, Psychology, Serotonin, Synapses, Neural Networks, Computer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review